Original Article Diabetes, obesity and metabolism Tirzepatide and Cancer Risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis Keypoint The authors conducted a meta-analysis including all relevant randomized controlled trials to assess the cancer risk associated with tirzepatide
The MetabolicJoint Connection Carrying extra body weight puts significant stress on the joints, especially the knees, hips, and spine
Based on data from the phase 2 clinical trial of retatrutide (NCT04881760), published in the New England Journal of Medicine in 2023, gastrointestinal adverse events were among the most frequently reported side effects across all dose groups
The FDA has noted that semaglutide sodium and semaglutide acetate are different active ingredients than those used in approved drugs, and similar concerns may apply to compounded tirzepatide formulations
No fine print, no gimmicks just a straightforward path to a healthier you